Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on peptides and GLP-1. Browse all Peptides & GLP-1 education

Raw genetic data is unreadable. A file with 700,000+ genetic markers means nothing on its own — and that's the gap most genetic testing companies never close. The Precision Peptide Genetic Test closes it through a pipeline that starts with a saliva sample and ends with 150+ personalized insights across 14 pathways, 49 peptides, and 150+ genetic insights. AI analysis is the layer that translates raw genotype data into actionable understanding. This post walks through how that pipeline actually works — genotyping, variant analysis, pathway mapping, and report synthesis — and why the AI layer is what separates a useful peptide genetic test from a data dump.

Step 1 — Sample Collection and Genotyping

It starts with saliva. You mail your sample to a CLIA-certified lab, where DNA is extracted and loaded onto an Illumina Global Screening Array — the same genotyping chip used in clinical research settings worldwide. The array reads hundreds of thousands of specific genetic positions (single nucleotide polymorphisms, or SNPs) across your genome, generating a raw genotype file. For peptide-relevant biology, the Precision Peptide Genetic Test focuses on 57 SNPs across 48 genes — carefully selected for their research-backed role in the pathways peptide protocols target.

Step 2 — Variant Calling and Quality Control

Raw genotype calls need validation. Each SNP gets called against reference data, and quality control thresholds flag any positions where the genotype read is ambiguous. The CLIA certification matters here — it's the regulatory framework that governs laboratory quality controls, chain of custody, and technical standards for clinical-grade genotyping. Non-CLIA labs can generate interesting data; CLIA labs generate data you and a qualified healthcare provider can have a real conversation about.

Step 3 — Where AI Takes Over: Variant-to-Insight Translation

Here's where most consumer genetic tests stop and where the Precision Peptide Genetic Test starts doing the harder work. A raw variant — say, FTO rs9939609 in the AA genotype — is technically informative but practically useless to a reader. AI analysis maps that raw call against the research literature that connects FTO variants to appetite regulation, satiety signaling, and the GLP-1 receptor pathway. It contextualizes it against your other weight-management variants (MC4R, TCF7L2, GLP1R, PPARG, and more). And it translates the combined picture into an insight a reader can actually use. Multiply by 57 SNPs across 14 pathways, and the complexity is why manual interpretation doesn't scale — and why AI is the only practical way to deliver 150+ insights from a single test.

Step 4 — Pathway-Level Synthesis

Individual variants tell fragments of a story; pathways tell the whole story. The AI layer groups related variants by biological system: 34 insights on Weight Management, 17 on Longevity & Aging, 15 on Muscle Growth, 14 on Skin Health, 12 on Energy Metabolism, and so on across all 14 pathways. Within each pathway, variants interact. A slow-COMT variant means more when paired with a slow-MTHFR variant because they both constrain methylation capacity. An FTO appetite-regulation variant means more when paired with a TCF7L2 glucose-metabolism variant because they both influence weight management biology. AI pattern-matching catches those interactions — which is the part no spreadsheet can replicate.

Step 5 — Personalized Report Generation

The output is a report, not a data file. Each insight is written in plain language: what the variant is, what the research says about it, what it means for the pathways peptide protocols target, and how it interacts with adjacent variants. The report is delivered through the secure PlexusDx Results Portal. No interpretation is required on your end — though the Peptide Pathways Report extends the analysis with a deeper synthesis layer for readers who want cross-pathway actionability.

Why AI Analysis Changes the Precision Health Equation

Before AI analysis, personalized genetic interpretation at scale was impossible. A certified genetic counselor could spend an hour interpreting a handful of variants for a single client. Now the same depth of interpretation runs across 150+ insights in minutes, and the results are consistent, repeatable, and auditable. For peptide protocols specifically, this matters because peptide biology is high-dimensional — no single gene controls a pathway. The AI layer is the only tool that can synthesize dozens of variants into a coherent pathway-level picture, which is what makes the Precision Peptide Genetic Test the foundation of the broader precision health stack. For more on what that stack looks like, see our guide to genetic peptide testing.

Genetics as a Guide, Not a Guarantee

AI analysis is powerful — but it's not omniscient. It interprets what the research currently shows about specific variants in specific pathways. It doesn't predict drug response to any named compound. It doesn't diagnose conditions. It doesn't replace the expertise of a qualified healthcare provider. What it does is give you and your provider the most informative starting point available in the market today — a genetic map to inform the conversation before any peptide protocol decision. That's the entire premise of testing before you invest.

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

Ready to understand what your genes say about your peptide response? Take the Precision Peptide Genetic Test

Frequently Asked Questions

How does AI analyze my DNA in a peptide genetic test?

AI maps your raw SNP data to the research on each variant, translates individual genotypes into pathway-level insights, and synthesizes interactions across genes. The Precision Peptide Genetic Test analyzes 57 SNPs across 48 genes, processed via Illumina Global Screening Array at CLIA-certified labs. Output: 150+ insights across 14 pathways and 49 peptides.

Is AI interpretation of genetic data accurate?

AI interpretation is only as accurate as the research behind each variant. The Precision Peptide Genetic Test uses well-studied SNPs with published pathway associations — FTO for appetite, FOXO3 for longevity, ACTN3 for muscle fiber type. AI contextualizes across variants; the research grounds each insight. Output consistency is audited at the CLIA-certified lab layer.

What's the difference between raw DNA data and AI-analyzed insights?

Raw DNA data is a list of genotype calls — unreadable without interpretation. AI analysis translates calls into pathway-level insights: what each variant means, how variants interact, and which of 14 pathways are most relevant. The Precision Peptide Genetic Test delivers 150+ insights — which is why AI analysis is the core of the product.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.